Filing Details
- Accession Number:
- 0001593968-21-001129
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-20 16:15:00
- Reporting Period:
- 2021-04-19
- Accepted Time:
- 2021-04-20 16:15:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 887359 | Vericel Corp | VCEL | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1313403 | Dominick Colangelo | C/O Vericel Corporation 64 Sidney Street Cambridge MA 02139 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-19 | 8,990 | $59.13 | 166,420 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-19 | 7,563 | $25.80 | 173,983 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-19 | 14,760 | $57.92 | 159,223 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-04-19 | 16,250 | $57.46 | 142,973 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-04-19 | 7,563 | $0.00 | 7,563 | $25.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,938 | 2023-03-06 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020.
- These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- The Reporting Person has elected to exercise and hold these shares at this time.
- These options, representing the right to purchase 55,001 shares, became exercisable on March 6, 2014, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal monthly installments over three years thereafter, contingent upon continued service to the Company.
Billionaire Hedge Funds
